Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan
Takuto Hara,
Yuto Matsushita,
Kenichi Harada
et al.
Abstract:Enfortumab vedotin (EV) displayed high efficacy in patients with metastatic urothelial carcinoma (UC) in the EV301 trial. 1 To date, few reports have described the real-world use of EV, and thus, established prognostic factors in UC patients treated with EV remain unavailable. In the present retrospective, multicenter study, we comprehensively evaluated the therapeutic efficacy, prognostic factors, and safety profile of this innovative therapeutic modality.This study included 78 advanced UC patients previously… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.